The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 27, 2016

Filed:

Aug. 29, 2012
Applicants:

Gunter Fischer, Halle, DE;

Miroslav Malesevic, Halle, DE;

Frank Erdmann, Halle, DE;

Jan Kuhling, Halle, DE;

Michael Bukrinsky, Potomac, MD (US);

Stephanie Constant, Herndon, VA (US);

Gerd Ruhter, Hamburg, DE;

Peter Nussbaumer, Dortmund, DE;

Klaus Dinkel, Bochum, DE;

Inventors:

Gunter Fischer, Halle, DE;

Miroslav Malesevic, Halle, DE;

Frank Erdmann, Halle, DE;

Jan Kuhling, Halle, DE;

Michael Bukrinsky, Potomac, MD (US);

Stephanie Constant, Herndon, VA (US);

Gerd Ruhter, Hamburg, DE;

Peter Nussbaumer, Dortmund, DE;

Klaus Dinkel, Bochum, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/12 (2006.01); C07K 7/50 (2006.01); C07K 7/64 (2006.01); C12N 9/90 (2006.01);
U.S. Cl.
CPC ...
C07K 7/645 (2013.01); C12N 9/90 (2013.01); C12Y 502/01008 (2013.01);
Abstract

The present invention relates to novel cyclosporin derivatives that do not cross the cellular membrane. The compounds according to the invention are used in medicine, more particularly in the treatment/diagnosis of acute and chronic inflammatory diseases, viral infections, cancer, degenerative muscle diseases, neurodegenerative diseases and damage that is associated with calcium homeostasis impairment. The novel cyclosporin derivatives additionally have no immunosuppressive effect.


Find Patent Forward Citations

Loading…